Resource Library

Whether or not someone continues GLP-1 therapy is a clinical decision that should be made in partnership with their healthcare provider. But what are the strategic benefits, and what are the risks?

MASH is one of the fastest-growing and most overlooked drivers of metabolic risk and rising healthcare costs.

For plan sponsors, the decisions made today will shape costs, outcomes, and member trust for years to come. A smarter strategy blends access, affordability, and clinical excellence rather than forcing tradeoffs.

At Vida, we know our medical team is at the heart of everything we do. In this new series, we’re spotlighting the physicians, dietitians, and coaches who bring their expertise and compassion to every member interaction. Each profile highlights their unique journeys, the impact they’ve made helping members manage chronic conditions, and the knowledge they bring to advancing evidence-based care.

At Vida, we know our medical team is at the heart of everything we do. In this new series, we’re spotlighting the physicians, dietitians, and coaches who bring their expertise and compassion to every member interaction. Each profile highlights their unique journeys, the impact they’ve made helping members manage chronic conditions, and the knowledge they bring to advancing evidence-based care.

For too long, culture has framed this transition as the beginning of invisibility or loss. In reality, it’s an opportunity to take up space, rebuild strength, and redefine what thriving looks like in midlife. It’s just a matter of knowing how.

Plan sponsors don’t just need to save money today; they need to ensure that those savings don’t backfire tomorrow in the form of worse outcomes and higher costs.

At Vida, we know our medical team is at the heart of everything we do. In this new series, we’re spotlighting the physicians, dietitians, and coaches who bring their expertise and compassion to every member interaction. Each profile highlights their unique journeys, the impact they’ve made helping members manage chronic conditions, and the knowledge they bring to advancing evidence-based care.

Though it can be entertaining, it’s confusing. And if you’re trying to figure out what actually works, it’s exhausting.

Let’s recognize what’s really going on when we cope with comfort food.

Obesity isn’t a willpower problem, and it never was.

Following our recent webinar with Amwell, Dr. Cynthia Horner, chief medical officer for Amwell, explored the issues plaguing the healthcare industry when it comes to cardiometabolic health and whole-person care.